The value of fast-acting insulin aspart compared with insulin aspart for patients with diabetes mellitus treated with bolus insulin from a UK health care system perspective

BACKGROUND: Fast-acting insulin aspart is a new formulation of the rapid-acting insulin analogue insulin aspart and represents an advancement over current rapid-acting insulin analogues in terms of onset of action and postprandial glucose control. The objective of the current analysis was to demonst...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ther Adv Endocrinol Metab
Autors principals: Leelarathna, Lalantha, Ashley, Donna, Fidler, Carrie, Parekh, Witesh
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6022975/
https://ncbi.nlm.nih.gov/pubmed/29977497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2042018818766816
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars